US$ 22.99
what is glp-1 agonist Agonists - it? A schematic overview of GLP-1
Description
reduction of systemic inflammation
Linge J, Birkenfeld AL, Neeland IJ

The trials have been published between 2015 and 2021

Data analysed by one-way ANOVA, multiple comparison, Bonferroni post hoc test ( c , e , g , l , n , p , v , x and z ) and two-way repeated measures ANOVA to assess main effects of treatment ( i , j , q , s and t )

N Engl J Med 2014;370:794797 [DOI] [PubMed] [Google Scholar] 42.Giorda CB, Sacerdote C, Nada E, Marafetti L, Baldi I, Gnavi R

Effects of saxagliptin on early microvascular changes in patients with type 2 diabetes
